Skip to main content

Advertisement

Open Peer Review Reports for: Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27 Kip1

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
11 Oct 2010 Submitted Original manuscript
3 Nov 2010 Reviewed Reviewer Report - Andreas Gescher
3 Nov 2010 Reviewed Reviewer Report - Alessandra Mocali
5 Dec 2010 Author responded Author comments - Hua-Qin Wang
Resubmission - Version 2
5 Dec 2010 Submitted Manuscript version 2
10 Dec 2010 Reviewed Reviewer Report - Andreas Gescher
16 Dec 2010 Reviewed Reviewer Report - Alessandra Mocali
20 Jan 2011 Author responded Author comments - Hua-Qin Wang
Resubmission - Version 3
20 Jan 2011 Submitted Manuscript version 3
8 Feb 2011 Author responded Author comments - Hua-Qin Wang
Resubmission - Version 4
8 Feb 2011 Submitted Manuscript version 4
3 Mar 2011 Author responded Author comments - Hua-Qin Wang
Resubmission - Version 5
3 Mar 2011 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
9 Mar 2011 Author responded Author comments - Hua-Qin Wang
Resubmission - Version 7
9 Mar 2011 Submitted Manuscript version 7
Publishing
19 Mar 2011 Editorially accepted
19 Mar 2011 Article published 10.1186/1471-2407-11-99

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement